Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02432235
Title Study of ADCT-301 in Patients With Relapsed or Refractory Hodgkin and Non-Hodgkin Lymphoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors ADC Therapeutics S.A.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR

Facility Status City State Zip Country Details
City of Hope (City of Hope National Medical Center, City of Hope Medical Center) Duarte California 91010 United States Details
Memorial Sloan-Kettering Cancer Center New York New York 10065 United States Details
University Hospitals Cleveland Medical Center Cleveland Ohio 44106 United States Details
The University of Texas/MD Anderson Cancer Center Houston Texas 77030-4009 United States Details
Cancer Therapy and Research Center at The University of Texas Health Science Center at San Antonio San Antonio Texas 78229 United States Details
Virginia Cancer Specialists, PC Fairfax Virginia 22031 United States Details
Froedtert Hospital/Medical College of Wisconsin Milwaukee Wisconsin 53226 United States Details
Guy's and St. Thomas' Hospital NHS Trust London England SE1 9RT United Kingdom Details
The Newcastle Upon Tyne Hospitals NHS Foundation Trust Newcastle upon Tyne England United Kingdom Details
Churchill Hospital, Oxford University Hospitals NHS Foundation Trust Oxford England OX3 7LE United Kingdom Details
The Christie NHS Foundation Trust Manchester Greater Manchester M20 4BX United Kingdom Details
Southampton General Hospital, University Hospital Southampton NHS Foundation Trust Southampton Hampshire United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field